Literature DB >> 956373

Effects of antihistamines on the lung vascular response to histamine in unanesthetized sheep. Diphenhydramine prevention of pulmonary edema and increased permeability.

K L Brigham, R E Bowers, P J Owen.   

Abstract

To see whether antihistamines could prevent and reverse histamine-induced pulmonary edema and increased lung vascular permeability, we compared the effects of a 4-h intravenous infusion of 4 mug/kg per min histamine phosphate on pulmonary hemodynamics, lung lymph flow, lymph and plasma protein content, arterial blood gases, hematocrit, and lung water with the effects of an identical histamine infusion given during an infusion of diphenhydramine or metiamide on the same variables in unanesthetized sheep. Histamine caused lymph flow to increase from 6.0+/-0.5 to 27.0+/-5.5 (SEM) ml/h (P less than 0.05), lymph; plasma globulin concentration ratio to increase from 0.62+/-0.01 to 0.67+/-0.02 (P less than 0.05), left atrial pressure to fall from 1+/-1 to -3+/-1 cm H2O (P less than 0.05), and lung lymph clearance of eight protein fractions ranging from 36 to 96 A molecular radius to increase significantly. Histamine also caused increases in lung water, pulmonary vascular resistance, arterial PCO2, pH, and hematocrit, and decreases in cardiac output and arterial PO2. Diphenhydramine (3 mg/kg before histamine followed by 1.5 mg/kg per h intravenous infusion) completely prevented the histamine effect on hematocrit, lung lymph flow, lymph protein clearance, and lung water content, and reduced histamine effects on arterial blood gases and pH. 6 mg/kg diphenhydramine given at the peak histamine response caused lymph flow and lymph: plasma protein concentration ratios to fall. Metiamide (10 mg/kg per h) did not affect the histamine lymph response. We conclude that diphenhydramine can prevent histamine-induced pulmonary edema and can prevent and reverse increased lung vascular permeability caused by histamine, and that histamine effects on lung vascular permeability are H1 actions.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 956373      PMCID: PMC333194          DOI: 10.1172/JCI108483

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  15 in total

1.  MEASUREMENT OF PULMONARY EDEMA.

Authors:  M L PEARCE; J YAMASHITA; J BEAZELL
Journal:  Circ Res       Date:  1965-05       Impact factor: 17.367

Review 2.  Pulmonary edema. 2.

Authors:  E D Robin; C E Cross; R Zelis
Journal:  N Engl J Med       Date:  1973-02-08       Impact factor: 91.245

3.  Definition and antagonism of histamine H 2 -receptors.

Authors:  J W Black; W A Duncan; C J Durant; C R Ganellin; E M Parsons
Journal:  Nature       Date:  1972-04-21       Impact factor: 49.962

4.  Indicator dilution measurements of extravascular water in the lungs.

Authors:  C A Goresky; R F Cronin; B E Wangel
Journal:  J Clin Invest       Date:  1969-03       Impact factor: 14.808

5.  Histamine and interstitial pulmonary edema in the dog.

Authors:  G G Pietra; J P Szidon; M M Leventhal; A P Fishman
Journal:  Circ Res       Date:  1971-10       Impact factor: 17.367

6.  Mechanism of the serotonin effect on lung transvascular fluid and protein movement in awake sheep.

Authors:  K L Brigham; P J Owen
Journal:  Circ Res       Date:  1975-06       Impact factor: 17.367

7.  In vivo assessment of pulmonary vascular integrity in experimental pulmonary edema.

Authors:  K L Brigham; J D Snell
Journal:  J Clin Invest       Date:  1973-08       Impact factor: 14.808

8.  The effects of the H1 and H2 antihistamines on "allergic" histamine release and its inhibition by histamine.

Authors:  L M Lichtenstein; E Gillespie
Journal:  J Pharmacol Exp Ther       Date:  1975-02       Impact factor: 4.030

9.  Increased sheep lung vascular permeability caused by pseudomonas bacteremia.

Authors:  K L Brigham; W C Woolverton; L H Blake; N C Staub
Journal:  J Clin Invest       Date:  1974-10       Impact factor: 14.808

10.  The effects of alloxan and histamine on the permeability of the pulmonary alveolocapillary barrier to albumin.

Authors:  B W Goetzman; M B Visscher
Journal:  J Physiol       Date:  1969-09       Impact factor: 5.182

View more
  6 in total

Review 1.  Molecular mechanisms of endothelial hyperpermeability: implications in inflammation.

Authors:  Puneet Kumar; Qiang Shen; Christopher D Pivetti; Eugene S Lee; Mack H Wu; Sarah Y Yuan
Journal:  Expert Rev Mol Med       Date:  2009-06-30       Impact factor: 5.600

2.  Therapy of ARDS: positive end-expiratory pressure.

Authors:  D H Simmons
Journal:  West J Med       Date:  1979-03

3.  Pulmonary vascular effects of fat emulsion infusion in unanesthetized sheep. Prevention by indomethacin.

Authors:  C R McKeen; K L Brigham; R E Bowers; T R Harris
Journal:  J Clin Invest       Date:  1978-05       Impact factor: 14.808

4.  Correlation of oxygenation with vascular permeability-surface area but not with lung water in humans with acute respiratory failure and pulmonary edema.

Authors:  K L Brigham; K Kariman; T R Harris; J R Snapper; G R Bernard; S L Young
Journal:  J Clin Invest       Date:  1983-07       Impact factor: 14.808

5.  Methylprednisolone prevention of increased lung vascular permeability following endotoxemia in sheep.

Authors:  K L Brigham; R E Bowers; C R McKeen
Journal:  J Clin Invest       Date:  1981-04       Impact factor: 14.808

6.  Nedocromil sodium and diphenhydramine HCl ameliorate exercise-induced arterial hypoxemia in highly trained athletes.

Authors:  Michael A Coyle; Curtis S Goss; Wesley J Manz; Joel T Greenshields; Robert F Chapman; Joel M Stager
Journal:  Physiol Rep       Date:  2022-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.